Alternative Glucose Monitoring Strategy

Abstract – Labquality Days 2018


The FreeStyle Libre Flash Glucose Monitoring System – enriched opportunities in diabetes management

Advanced glucose control - Labquality Days 2018The prevalence of diabetes is achieving epidemic proportions and a multifactorial approach is required to reduce the risk of complications and consequent morbidity and mortality. Glycemic control remains key to reducing microvascular complications and long-term macrovascular disease. However, this risk factor is difficult to control, given the large daily fluctuations in glucose levels secondary to activities and treatment modalities. In particular, overtreatment of hyperglycemia precipitates hypoglycemia, which is associated with adverse clinical outcomes. Moreover, repeated hypoglycemia results in increased glucose variability, which appears to be associated with increased risk of diabetes complications.

The current presentation reviews the relationship between clinical outcomes and various glycemic markers, providing a summary to the background of “The Triangle of Diabetes Care”. The relationship between frequency of glucose testing and glycemic control is also reviewed and the role of flash glucose monitoring in improving glucose levels is addressed.

Key randomized controlled trials investigating the benefits of flash glucose monitoring in type 1 and type 2 diabetes are discussed, including the recently published IMPACT and REPLACE studies. Moreover, real life data of more than 390 million glucose readings and over 64 million scans are presented, analyzing the association between frequency of glucose testing and glycemic control. With the advent of an alternative glucose monitoring strategy, optimizing glucose control in diabetes is becoming easier for both patients and health care professionals, helping to improve outcomes in this high risk population.

Welcome to Helsinki and International Congress on Quality in Laboratory Medicine to learn more. Dr. Alexander Seibold will give his presentation on Friday 9 February, 2018.


Dr. Alexander Seibold
Regional Medical Director EMEAP, Abbott Diabetes Care

Education in internal medicine, endocrinology and diabetology.
Since 2016 Regional Medical Director Europe, Middle East, Africa and Pakistan, Abbott Diabetes Care
2013 to 2015 “Vice President Sales”, Ziemer Ophthalmic Systems AG (CH)
2004 to 2012 Ypsomed AG (CH); last position “Vice President Sales Diabetes Care”
2000 to 2003 “Head of Medical and Scientific Affairs”, Disetronic Medical Systems GmbH, (D)
1993 to 2000 Physician at the University Hospital Ulm (D)


International Congress on Quality in Laboratory Medicine 8-9 February, 2018 Helsinki, Finland

Register now and ensure your participation to the most interesting congress in medical laboratory field in 2018. Scientific program deals with quality issues of laboratory medicine and advanced healthcare technologies. Two inspiring days with world class speakers will guarantee an unforgettable experience. Read more on

See you in Helsinki!